PUBLICATIONS
LINKS
SPECIAL MEMBERS / SPONSORS
JOIN THE EBC
English
日本語
ABOUT
History & Core Mission
Organisation
EBC Constitution
Regulatory Expertise and Services
FAQ
EBC in the Media
EBO Worldwide Network
COMMITTEES
Business Fundamentals
Financial Services
Transportation & Communications
Health Science
Consumer Goods
Industry
Members List
EBC Achievements
Digital White Paper
All Issues
New Issues
Resolved Issues
NEWS
Event
Newsletter
Press Releases
Statements
Survey
CONTACT
HOME
ABOUT
COMMITTEES
SPECIAL MEMBERS / SPONSORS
PUBLICATIONS
JOIN THE EBC
EU and Japan: Avenues for Cooperation
All Issues
New Issues
Resolved Issues
NEWS
LINKS
CONTACT
Issues
ALL
New
Not prioritised
Progress
Resolved
Urgent
Committee:
All
Cross-Committee Issues
Human Resources
Intellectual Property Rights
Legal Services
Retail & Wholesale
Sustainability & Social Responsibility
Tax
Food & Agriculture
Liquor
Asset Management
Insurance
Banking
IVD (In Vitro Diagnostics)
Pharmaceuticals
Vaccines
Cosmetics & Quasi-drugs
Medical Equipment
Aeronautics
Automobile
Automotive Components & Aftermarket
Energy
Materials
Space
Defence & Security
Airlines
Logistics & Freight
Railways
Telecommunications Equipment
Print
Health Science
IVD (In Vitro Diagnostics)
Published:
November 29, 2021
Rationalisation of regulations on IVD and streamline operations
status:
Some progress
